Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.
Studies of pharmacogenomics-related traits are increasingly being performed to identify loci that affect either drug response or susceptibility to adverse drug reactions. However, the effect of the polymorphisms can differ in magnitude or be absent depending on the population being assessed. We used...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4242606?pdf=render |
id |
doaj-7dafe6726fa84760ba9b0b6d08a5c2cf |
---|---|
record_format |
Article |
spelling |
doaj-7dafe6726fa84760ba9b0b6d08a5c2cf2020-11-25T00:23:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e11264010.1371/journal.pone.0112640Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.Vania Bonifaz-PeñaAlejandra V ContrerasClaudio Jose StruchinerRosimeire A RoelaTatiane K Furuya-MazzottiRoger ChammasClaudia Rangel-EscareñoLaura Uribe-FigueroaMaría José Gómez-VázquezHoward L McLeodAlfredo Hidalgo-MirandaEsteban J ParraJuan Carlos Fernández-LópezGuilherme Suarez-KurtzStudies of pharmacogenomics-related traits are increasingly being performed to identify loci that affect either drug response or susceptibility to adverse drug reactions. However, the effect of the polymorphisms can differ in magnitude or be absent depending on the population being assessed. We used the Affymetrix Drug Metabolizing Enzymes and Transporters (DMET) Plus array to characterize the distribution of polymorphisms of pharmacogenetics and pharmacogenomics (PGx) relevance in two samples from the most populous Latin American countries, Brazil and Mexico. The sample from Brazil included 268 individuals from the southeastern state of Rio de Janeiro, and was stratified into census categories. The sample from Mexico comprised 45 Native American Zapotecas and 224 self-identified Mestizo individuals from 5 states located in geographically distant regions in Mexico. We evaluated the admixture proportions in the Brazilian and Mexican samples using a panel of Ancestry Informative Markers extracted from the DMET array, which was validated with genome-wide data. A substantial variation in ancestral proportions across census categories in Brazil, and geographic regions in Mexico was identified. We evaluated the extent of genetic differentiation (measured as FST values) of the genetic markers of the DMET Plus array between the relevant parental populations. Although the average levels of genetic differentiation are low, there is a long tail of markers showing large frequency differences, including markers located in genes belonging to the Cytochrome P450, Solute Carrier (SLC) and UDP-glucuronyltransferase (UGT) families as well as other genes of PGx relevance such as ABCC8, ADH1A, CHST3, PON1, PPARD, PPARG, and VKORC1. We show how differences in admixture history may have an important impact in the distribution of allele and genotype frequencies at the population level.http://europepmc.org/articles/PMC4242606?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vania Bonifaz-Peña Alejandra V Contreras Claudio Jose Struchiner Rosimeire A Roela Tatiane K Furuya-Mazzotti Roger Chammas Claudia Rangel-Escareño Laura Uribe-Figueroa María José Gómez-Vázquez Howard L McLeod Alfredo Hidalgo-Miranda Esteban J Parra Juan Carlos Fernández-López Guilherme Suarez-Kurtz |
spellingShingle |
Vania Bonifaz-Peña Alejandra V Contreras Claudio Jose Struchiner Rosimeire A Roela Tatiane K Furuya-Mazzotti Roger Chammas Claudia Rangel-Escareño Laura Uribe-Figueroa María José Gómez-Vázquez Howard L McLeod Alfredo Hidalgo-Miranda Esteban J Parra Juan Carlos Fernández-López Guilherme Suarez-Kurtz Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. PLoS ONE |
author_facet |
Vania Bonifaz-Peña Alejandra V Contreras Claudio Jose Struchiner Rosimeire A Roela Tatiane K Furuya-Mazzotti Roger Chammas Claudia Rangel-Escareño Laura Uribe-Figueroa María José Gómez-Vázquez Howard L McLeod Alfredo Hidalgo-Miranda Esteban J Parra Juan Carlos Fernández-López Guilherme Suarez-Kurtz |
author_sort |
Vania Bonifaz-Peña |
title |
Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. |
title_short |
Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. |
title_full |
Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. |
title_fullStr |
Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. |
title_full_unstemmed |
Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. |
title_sort |
exploring the distribution of genetic markers of pharmacogenomics relevance in brazilian and mexican populations. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Studies of pharmacogenomics-related traits are increasingly being performed to identify loci that affect either drug response or susceptibility to adverse drug reactions. However, the effect of the polymorphisms can differ in magnitude or be absent depending on the population being assessed. We used the Affymetrix Drug Metabolizing Enzymes and Transporters (DMET) Plus array to characterize the distribution of polymorphisms of pharmacogenetics and pharmacogenomics (PGx) relevance in two samples from the most populous Latin American countries, Brazil and Mexico. The sample from Brazil included 268 individuals from the southeastern state of Rio de Janeiro, and was stratified into census categories. The sample from Mexico comprised 45 Native American Zapotecas and 224 self-identified Mestizo individuals from 5 states located in geographically distant regions in Mexico. We evaluated the admixture proportions in the Brazilian and Mexican samples using a panel of Ancestry Informative Markers extracted from the DMET array, which was validated with genome-wide data. A substantial variation in ancestral proportions across census categories in Brazil, and geographic regions in Mexico was identified. We evaluated the extent of genetic differentiation (measured as FST values) of the genetic markers of the DMET Plus array between the relevant parental populations. Although the average levels of genetic differentiation are low, there is a long tail of markers showing large frequency differences, including markers located in genes belonging to the Cytochrome P450, Solute Carrier (SLC) and UDP-glucuronyltransferase (UGT) families as well as other genes of PGx relevance such as ABCC8, ADH1A, CHST3, PON1, PPARD, PPARG, and VKORC1. We show how differences in admixture history may have an important impact in the distribution of allele and genotype frequencies at the population level. |
url |
http://europepmc.org/articles/PMC4242606?pdf=render |
work_keys_str_mv |
AT vaniabonifazpena exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT alejandravcontreras exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT claudiojosestruchiner exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT rosimeirearoela exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT tatianekfuruyamazzotti exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT rogerchammas exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT claudiarangelescareno exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT laurauribefigueroa exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT mariajosegomezvazquez exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT howardlmcleod exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT alfredohidalgomiranda exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT estebanjparra exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT juancarlosfernandezlopez exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations AT guilhermesuarezkurtz exploringthedistributionofgeneticmarkersofpharmacogenomicsrelevanceinbrazilianandmexicanpopulations |
_version_ |
1725355888657563648 |